Patents expiring in 2031

US 8030488

Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030493

Monovalent and divalent salts of N-(5-hydroxynicotinoil) -L-glutamic acid exhibiting psychotropic (antidepressant and anxiolytic), neuroprotective, geroprotective and cerebroprotective action

Obschestvo S Ogranichennoy Otvetstvennostyu “Natsionalnaya Isseldovatelskaya Kompaniya” · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030447

Substrate peptide sequences for plague plasminogen activator and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030337

Tricyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030341

Dmt-derivative compounds and related compositions and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8029788

Variants of humanized anti-carcinoma MAb CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030331

Allosteric modulators of metabotropic glutamate receptors

Addex Pharma, S.A. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030317

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030307

Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030333

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030280

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8030070

Artificial lymphoid tissue equivalent

SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8029826

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034832

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034821

Selective serine/threonine kinase inhibitors

The Regents of the University of California · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034825

Chemically modified small molecules

Nektar Therapeutics · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034826

Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034950

Processes for the facile synthesis of diaryl amines and analogues thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034334

Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034376

Lipid containing formulations

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034768

Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

The Board of Regents of the University of Texas System · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034812

Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof

Takeda Pharmaceutical Company Limited · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034946

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034822

Glucokinase activators

Takeda San Diego, Inc. · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034384

Method of increasing biocompatibility of medical device by generating nitric oxide

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034556

Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity

The Regents of the University of California · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034363

Sustained release systems of ascorbic acid phosphate

Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034329

Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells

Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034337

Interleukin-1α antibodies

XBIOTECH INC. · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8034793

RNAi modulation of MLL-AF4 and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039489

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039579

Intermediates useful in the preparation of maleimide functionalized polymers

Nektar Therapeutics · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039008

Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039627

Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039620

Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039623

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039661

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039593

Antibodies and immunotoxins that target human glycoprotein NMB

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039257

Pre-transplant accomodated organs resistant to anti-donor immunity

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039003

Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8038997

Anti-marinobufagenin antibodies and methods for their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039001

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039475

Co-crystals and pharmaceutical compositions comprising the same

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039500

Fused heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039491

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039585

Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043617

Human antibodies to human IL-6 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043625

Purified plasmodium and vaccine compositions

Sanaria Inc. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)